Jump to ContentJump to Main Navigation

Online

249,00 € / $374.00*

* Prices subject to change. Shipping costs will be added if applicable.
Publication Date:
August 2007
ISSN:
1437-4331
DOI:
10.1515/CCLM.2007.199

See all formats and pricing

Online
Individual Subscription Online only
Euro [D] 249.00
RRP for USA, Canada, Mexico
US$ 374.00 *
Print
Individual Subscription Online only
Euro [D] 1577.00
RRP for USA, Canada, Mexico
US$ 2365.00 *
Print + Online
Individual Subscription Online only
Euro [D] 1893.00
RRP for USA, Canada, Mexico
US$ 2838.00 *
*Prices subject to change. Shipping costs will be added if applicable.

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the International Federation of Clinical Chemistry and Laboratory Medicine and the European Federation of Clinical Chemistry and Laboratory Medicine

Editor-in-Chief: Plebani, Mario

Editorial Board Member: Lippi, Giuseppe / Gillery, Philippe / Kazmierczak, Steven / Lackner, Karl J. / Melichar, Bohuslav / Siest, Gérard / Whitfield, John B. / Abi Fadel, Marianne / Alvarez Menendez, Francisco V. / Azzazy, Hassan M.E. / Diamandis, Eleftherios P. / Eckardstein, Arnold / Favaloro, Emmanuel J. / Griesmacher, Andrea / Herrmann, Wolfgang / Hoffmann, Johannes J.M.L. / Hooijkaas, Herbert / Ichihara, Kiyoshi / Kaabachi, Naziha / Kim, Jeong-Ho / Korte, Wolfgang / Kroupis, Christos / Lai, Leslie Charles / Lam, Wai Kei Christopher / Marc, Janja / Miyoshi, Eiji / Özben, Tomris / Palicka, Vladimir / Panteghini, Mauro / Queralto, Jose M. / Scartezini, Marileia / Simundic, Ana-Maria / Tsongalis, Gregory J. / Wallemacq, Pierre E. / Yan, Shengkai / Young, Ian S. / Chiu, Rossa Wai Kwun / Ghosh, Debabrata / Kappelmayer, Janos / Lehmann, Sylvain / Sypniewska, Grazyna

12 Issues per year

Increased IMPACT FACTOR 2011: 2.150
Rank 10 out of 32 in category Medical Laboratory Technology in the 2011 Thomson Reuters Journal Citation Report/Science Edition

VolumeIssuePage

Issues

IFCC Position Paper: Report of the IFCC Taskforce on Ethics: Introduction and framework

Leslie Burnett1 / Matthew J. McQueen2 / Jon Johannes Jonsson3 / Francesca Torricelli4

1Pacific Laboratory Medicine Services (PaLMS), Royal North Shore Hospital, and Northern Clinical School, University of Sydney, Sydney, Australia

2Department of Laboratory Medicine, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada

3Division of Biochemistry, Clinical Biochemistry and Medical Genetics, University of Iceland Faculty of Medicine, and Department of Genetics and Molecular Medicine, Landspitali University Hospital, Reykjavik, Iceland

4Laboratory of Genetics and Cytogenetics, Careggi University Hospital, Florence, Italy

Corresponding author: Prof. Leslie Burnett, Pacific Laboratory Medicine Services (PaLMS), Executive Unit, Royal North Shore Hospital, Pacific Highway, St Leonards, Sydney, NSW 2065, Australia Phone: +61-2-99268086, Fax: +61-2-99266395,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 45, Issue 8, Pages 1098–1104, ISSN (Online) 14374331, ISSN (Print) 14346621, DOI: 10.1515/CCLM.2007.199, August 2007

Publication History:
Published Online:
2007-08-09

Abstract

Laboratory Medicine organizations and their professional members have a goal and responsibility to benefit the health and wellbeing of the patients and communities they serve. Newer genetics and biochemical techniques raise significant issues of community concern, impacting on privacy, informed consent, access to and retention of samples and information. Balance may be required to ensure protection of individual rights against potential benefits to the broader community. While many national organizations may already have appropriate policies addressing various ethics issues, there is a need for an international framework to assist those nations that have not yet developed such policies, as well as to enable alignment of existing national policies. We have proposed a generic ethics framework, incorporating a hierarchy of four fundamental guiding principles: autonomy, justice, non-maleficence and beneficence. Proposals or issues requiring policy development can be considered and tested against this hierarchy, resulting in the development of policy and positions consistent with the above framework, acceptable to all participating stakeholders.

Clin Chem Lab Med 2007;45:1098–104.

Keywords: ethics; laboratory medicine

Comments (0)

Please log in or register to comment.